This automated method of measurement is helpful in the investigation of some hematologic disorders and in monitoring response to therapy. The RDW is essentially an indication of the degree of anisocytosis (abnormal variation in size of RBCs). Normal RBCs have a slight degree of variation.
The CV of RDW is determined and calculated by the analyzer.
Use the CV of RDW with caution and not as a replacement for other diagnostic tests.
Use the following calculation:
The RDW can be helpful in distinguishing uncomplicated heterozygous thalassemia (low MCV, normal RDW) from iron-deficiency anemia (low MCV, high RDW).
The RDW can be helpful in distinguishing anemia of chronic disease (low-normal MCV, normal RDW) from early iron-deficiency anemia (low-normal MCV, elevated RDW).
Increased RDW occurs in:
Iron deficiency
Vitamin B12 (VB12) or folate deficiency (pernicious anemia)
Abnormal Hb: S, SC, or H
S-beta-thalassemia (homogeneous)
Immune hemolytic anemia
Marked reticulocytosis
Fragmentation of RBCs
Normal RDW—normal in anemias with homogeneous red cell size
Chronic disease
Acute blood loss
Aplastic anemia
Hereditary spherocytosis
Hb E disease
Sickle cell disease
There is no known cause of a decreased RDW.
Pretest Patient Care
Explain the purpose and procedure for testing. Assess for possible causes of anemia. No fasting is required.
Follow guidelines in Chapter 1 for safe, effective, informed pretest care.
Posttest Patient Care
Review test results; report and record findings; monitor appropriately for response to therapy. Modify the nursing care plan as needed.
Counsel the patient regarding abnormal findings and proper diet, medication, related hormone and enzyme problems, and genetically linked disorders. Explain the need for possible follow-up testing and treatment.
Follow guidelines in Chapter 1 for safe, effective, informed posttest care.